Skip to content

iStart Smart for Teens for Healthy Weight Management

Phase 1 Study of Fitbit and Apps on Healthy Weight Management in Obese Teens in Primary Care Clinics

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01693250
Enrollment
40
Registered
2012-09-26
Start date
2015-04-30
Completion date
2016-12-01
Last updated
2019-08-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obese, Overweight

Keywords

technology, healthy weight management, primary care setting

Brief summary

The emerging epidemic of type 2 diabetes mellitus (T2DM) in children is coupled with the increased prevalence of childhood obesity in the last two decades. Obesity during the adolescent years is associated with many adverse health consequences, including T2DM, hyperlipidemia, and psychosocial problems. The first step toward effective obesity management and T2DM prevention is monitoring of physical activity (PA) and dietary intake. With the rapid expansion of cellular networks, and advancements in smartphone technologies, it is now possible to monitor PA and dietary intake and at the same time to transmit data digitally to their primary care providers (PCP). The proposed pilot study will include the collaboration among UCSF, North East Medical Services (NEMS), mHealth teams, and overweight and/or obese adolescents. The study will adapt and implement smartphone-based technologies and integrate these technologies with the Electronic Health Record (EHR) to increase PA and dietary intake. Two specific aims of this proposed study include: (1) adapt fitbit Ultra applications for the smartphone-based technologies and EHR and (2) and assess the feasibility and estimate the effect for patient outcomes (self-efficacy, physical activity, dietary intake, BMI, and lipid profile), at 3 months post intervention between the intervention and control groups. The smartphone app for the intervention group will allow the teens to graphically compare daily PA and dietary intake with the goal, participate in a reward program where they can collect virtual points for achieving the goal, and play interactive games related to PA and diet. A total of 40 overweight and/or obese adolescents at NEMS will be recruited and randomized to the feasibility study (Aim 2).

Detailed description

Using evidence to inform the design of clinical practice is a foundational principle of modern health care practice. In the present pilot study, using evidence from research on technology in clinical practice facilitated development of a hybrid intervention that combined lifestyle modification with routine clinical care. Chief among the benefits of this hybrid smartphone technology-based intervention (STB) was the potential to improve health outcomes and reduce obesity in overweight and obese adolescents. The purposes of this study were to (1) measure effects of an innovative smartphone-technology-based (STB) intervention for overweight and obese adolescents and to (2) examine the intervention's feasibility for use in primary care clinics.The STB intervention had 3 components: use of Fitbit Flex, participation in the online educational program, and receipt of bi-weekly text message during the maintenance phase. A randomized control study design was utilized. Data regard to anthropometrics (BMI and waist-hip ratio), blood pressure, levels of physical and sedentary activity, diet, and self-efficacy regarding physical activity and diet were collected at baseline, 3 month and 6 months after the baseline assessment.

Interventions

BEHAVIORALfitbit Ultra

Participants will be asked to wear the Fitbit device and use the app every day for three months. The app functions will include tracking of PA and dietary intake progress, setting individualized and realistic goals, monitoring progress related to reaching the goals, providing tips of everyday activities, and having interactive games related to PA and healthy diet.

BEHAVIORALPedometer

adolescents in the control group will be given an Omron HJ-105 pedometer and a food diary and be asked to use them for three months.

Sponsors

University of California, San Francisco
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
DOUBLE (Caregiver, Outcomes Assessor)

Masking description

Primary care providers and outcome assessors were blinded to the group assignment.

Intervention model description

A randomized control study design with an active control group was used.

Eligibility

Sex/Gender
ALL
Age
13 Years to 18 Years
Healthy volunteers
Yes

Inclusion criteria

* between 13-18 years old * have a BMI at ≥ 85th percentile, based on CDC growth chart * own a smartphone; * have access to a computer with internet access * be able to read and speak English.

Exclusion criteria

* have acute or life-threatening disease * not be able to engage in activities of daily living

Design outcomes

Primary

MeasureTime frameDescription
Body Mass Index (BMI)baseline and 6 monthsParticipants' BMI was determined by dividing body mass (weight) by height squared (kg/m2). Adolescents' weight and height were measured while the adolescents wore light-weight clothes and no shoes. For BMI, adequate sensitivity and specificity has been reported in children and adolescents, with sensitivity ranging from 29% to 88% and specificity ranging from 94% to 100%.

Other

MeasureTime frameDescription
Diastolic Blood Pressurebaseline and 6 monthsSystolic blood pressure and diastolic blood pressure were measured by using a mercury sphygmomanometer with specific cuff size appropriate for adolescents (Baumanometer, W. A. Baum Co., Copiague, New York). After participants sat for 10 minutes, blood pressure was measured twice in the adolescent's right arm; blood pressures were measured to the nearest 2 mmHg. Average score of two measures was used.

Countries

United States

Participant flow

Recruitment details

The trained research assistant worked with primary care providers at two large community clinics whose patient populations were predominantly Chinese American in northern California. A study invitation letter was posted in the clinics. Pediatricians at the clinics were also given a study invitation letter to give to potential participants.

Pre-assignment details

An explanation of why potential participants were excluded from the study before assignment to groups was given them.

Participants by arm

ArmCount
Fitbit Ultra
Adolescents in the intervention group will receive a Fitbit Ultra and will download an app to their smartphone. Participants will be asked to wear the Fitbit device and use the app every day for three months. fitbit Ultra: Participants will be asked to wear the Fitbit device and use the app every day for three months. The app functions will include tracking of PA and dietary intake progress, setting individualized and realistic goals, monitoring progress related to reaching the goals, providing tips of everyday activities, and having interactive games related to PA and healthy diet.
23
Pedometer
After completion of the baseline assessments, adolescents in the control group will be given an Omron HJ-105 pedometer and a food diary and be asked to use them for three months. Pedometer: adolescents in the control group will be given an Omron HJ-105 pedometer and a food diary and be asked to use them for three months.
17
Total40

Withdrawals & dropouts

PeriodReasonFG000FG001
Overall StudyLost to Follow-up22

Baseline characteristics

CharacteristicFitbit UltraPedometerTotal
Age, Categorical
<=18 years
23 Participants17 Participants40 Participants
Age, Categorical
>=65 years
0 Participants0 Participants0 Participants
Age, Categorical
Between 18 and 65 years
0 Participants0 Participants0 Participants
Age, Continuous15.0 years
STANDARD_DEVIATION 1.66
14.8 years
STANDARD_DEVIATION 1.69
14.9 years
STANDARD_DEVIATION 1.67
Sex: Female, Male
Female
8 Participants9 Participants17 Participants
Sex: Female, Male
Male
15 Participants8 Participants23 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 230 / 17
other
Total, other adverse events
0 / 230 / 17
serious
Total, serious adverse events
0 / 230 / 17

Outcome results

Primary

Body Mass Index (BMI)

Participants' BMI was determined by dividing body mass (weight) by height squared (kg/m2). Adolescents' weight and height were measured while the adolescents wore light-weight clothes and no shoes. For BMI, adequate sensitivity and specificity has been reported in children and adolescents, with sensitivity ranging from 29% to 88% and specificity ranging from 94% to 100%.

Time frame: baseline and 6 months

ArmMeasureGroupValue (MEAN)Dispersion
Fitbit UltraBody Mass Index (BMI)baseline data27.37 kg/m^2Standard Deviation 3.26
Fitbit UltraBody Mass Index (BMI)6 months data26.93 kg/m^2Standard Deviation 3.42
PedometerBody Mass Index (BMI)baseline data28.35 kg/m^2Standard Deviation 4.36
PedometerBody Mass Index (BMI)6 months data29.18 kg/m^2Standard Deviation 3.88
Comparison: This is a feasibility and pilot study. We acknowledge that our sample size will not have adequate power to detect any statistically significant outcomes. We chose a sample size that would be large enough to assess feasibility and effect size and to accommodate recruitment within the study time and budget of this application. We hope to be able to estimate the effect size of the intervention.p-value: <0.001Mixed Models Analysis
Other Pre-specified

Diastolic Blood Pressure

Systolic blood pressure and diastolic blood pressure were measured by using a mercury sphygmomanometer with specific cuff size appropriate for adolescents (Baumanometer, W. A. Baum Co., Copiague, New York). After participants sat for 10 minutes, blood pressure was measured twice in the adolescent's right arm; blood pressures were measured to the nearest 2 mmHg. Average score of two measures was used.

Time frame: baseline and 6 months

Population: Adolescents who are overweight or obese were invited to participate in this study,

ArmMeasureGroupValue (MEAN)Dispersion
Fitbit UltraDiastolic Blood Pressurebaseline72.74 mmhgStandard Deviation 8.07
Fitbit UltraDiastolic Blood Pressure6 month70.15 mmhgStandard Deviation 7.53
PedometerDiastolic Blood Pressurebaseline69.94 mmhgStandard Deviation 11.25
PedometerDiastolic Blood Pressure6 month72.14 mmhgStandard Deviation 8.71
Comparison: We hypothesized the intervention group will have significant reduction of systematic blood pressure compared to the control group at 6 month follow up.p-value: 0.001Mixed Models Analysis

Source: ClinicalTrials.gov · Data processed: Feb 26, 2026